Algert Global’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Sell |
102,345
-21,070
| -17% | -$659K | 0.07% | 473 |
|
|
2025
Q1 | $4.14M | Sell |
123,415
-118,002
| -49% | -$3.96M | 0.1% | 336 |
|
|
2024
Q4 | $9.46M | Buy |
241,417
+21,772
| +10% | +$854K | 0.22% | 123 |
|
|
2024
Q3 | $8.65M | Buy |
219,645
+36,440
| +20% | +$1.43M | 0.23% | 107 |
|
|
2024
Q2 | $7.14M | Sell |
183,205
-810
| -0.4% | -$31.6K | 0.24% | 102 |
|
|
2024
Q1 | $7.92M | Sell |
184,015
-33,305
| -15% | -$1.43M | 0.31% | 65 |
|
|
2023
Q4 | $10M | Buy |
217,320
+88,833
| +69% | +$4.09M | 0.4% | 25 |
|
|
2023
Q3 | $4.39M | Sell |
128,487
-16,390
| -11% | -$560K | 0.21% | 144 |
|
|
2023
Q2 | $5.58M | Buy |
144,877
+106,470
| +277% | +$4.1M | 0.24% | 93 |
|
|
2023
Q1 | $1.38M | Buy |
38,407
+1,991
| +5% | +$71.3K | 0.06% | 501 |
|
|
2022
Q4 | $1.44M | Sell |
36,416
-8,830
| -20% | -$348K | 0.08% | 419 |
|
|
2022
Q3 | $1.63M | Buy |
45,246
+18,842
| +71% | +$680K | 0.1% | 344 |
|
|
2022
Q2 | $803K | Buy |
26,404
+14,330
| +119% | +$436K | 0.06% | 567 |
|
|
2022
Q1 | $369K | Buy |
+12,074
| New | +$369K | 0.02% | 911 |
|